Obstructive sleep apnea (OSA) is associated with cognitive impairment and increased risks of dementia. However, the effect of continuous positive airway pressure (CPAP) on cognitive function in patients with OSA is still controversial.
Objective:
To evaluate the cognitive effects of CPAP treatment on OSA.
Methods:
We systematically searched PubMed, EMBASE, and Cochrane Library for randomized controlled trials (RCT) in the corresponding fields.
Results:
Totally 14 studies and 1,926 participants were included in our meta-analysis. Standardized mean difference (SMD) or weighted mean difference (WMD) were calculated for subjective sleepiness and cognitive domains including attention and speed of information processing, executive function, and memory. Individual cognitive scale and subgroup analyses according to OSA severity, length of trial, and RCT design type were further conducted. Significant treatment effect on attention and speed of information processing was only observed in severe OSA patients (SMD, 0.17; 95% CI, 0.02 to 0.31; p = 0.025; I2 = 0%).
Conclusions:
Therefore, our meta-analysis indicates that CPAP treatment can partially improve cognitive impairment in the population of severe OSA.
SemelkaM, WilsonJ, FloydR (2016) Diagnosis and treatment of obstructive sleep apnea in adults. Am Fam Physician94, 355–360.
2.
BucksRS, OlaitheM, RosenzweigI, MorrellMJ (2017) Reviewing the relationship between OSA and cognition: Where do we go from here?Respirology22, 1253–1261.
3.
LimDC, PackAI (2017) Obstructive sleep apnea: Update and future. Annu Rev Med68, 99–112.
BarnesM, HoustonD, WorsnopCJ, NeillAM, MykytynIJ, KayA, TrinderJ, SaundersNA, Douglas McEvoyR, PierceRJ (2002) A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med165, 773–780.
6.
KernerNA, RooseSP (2016) Obstructive sleep apnea is linked to depression and cognitive impairment: Evidence and potential mechanisms. Am J Geriatr Psychiatry24, 496–508.
7.
LimDC, PackAI (2014) Obstructive sleep apnea and cognitive impairment: Addressing the blood-brain barrier. Sleep Med Rev18, 35–48.
8.
ChenHL, LuCH, LinHC, ChenPC, ChouKH, LinWM, TsaiNW, SuYJ, FriedmanM, LinCP, LinWC (2015) White matter damage and systemic inflammation in obstructive sleep apnea. Sleep38, 361–370.
9.
BarilAA, CarrierJ, LafreniereA, WarbyS, PoirierJ, OsorioRS, AyasN, DubeMP, PetitD, GosselinN (2018) Biomarkers of dementia in obstructive sleep apnea. Sleep Med Rev42, 139–148.
10.
EiseleHJ, MarkartP, SchulzR (2015) Obstructive sleep apnea, oxidative stress, and cardiovascular disease: Evidence from human studies. Oxid Med Cell Longev2015, 608438.
11.
SharmaRA, VargaAW, BubuOM, PirragliaE, KamK, ParekhA, WohlleberM, MillerMD, AndradeA, LewisC, TweardyS, BujM, YauPL, SaddaR, MosconiL, LiY, ButlerT, GlodzikL, FieremansE, BabbJS, BlennowK, ZetterbergH, LuSE, BadiaSG, RomeroS, RosenzweigI, GosselinN, Jean-LouisG, RapoportDM, de LeonMJ, AyappaI, OsorioRS (2018) Obstructive sleep apnea severity affects amyloid burden in cognitively normal elderly. A longitudinal study. Am J Respir Crit Care Med197, 933–943.
12.
KushidaCA, NicholsDA, HolmesTH, QuanSF, WalshJK, GottliebDJ, SimonRDJr, GuilleminaultC, WhiteDP, GoodwinJL, SchweitzerPK, LearyEB, HydePR, HirshkowitzM, GreenS, McEvoyLK, ChanC, GevinsA, KayGG, BlochDA, CrabtreeT, DementWC (2012) Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES). Sleep35, 1593–1602.
13.
AaronsonJA, HofmanWF, van BennekomCA, van BezeijT, van den AardwegJG, GroetE, KylstraWA, SchmandB (2016) Effects of continuous positive airway pressure on cognitive and functional outcome of stroke patients with obstructive sleep apnea: A randomized controlled trial. J Clin Sleep Med12, 533–541.
14.
BarbeF, MayoralasLR, DuranJ, MasaJF, MaimoA, MontserratJM, MonasterioC, BoschM, LadariaA, RubioM, RubioR, MedinasM, HernandezL, VidalS, DouglasNJ, AgustiAG (2001) Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med134, 1015–1023.
15.
BardwellWA, Ancoli-IsraelS, BerryCC, DimsdaleJE (2001) Neuropsychological effects of one-week continuous positive airway pressure treatment in patients with obstructive sleep apnea: A placebo-controlled study. Psychosom Med63, 579–584.
16.
PanYY, DengY, XuX, LiuYP, LiuHG (2015) Effects of continuous positive airway pressure on cognitive deficits in middle-aged patients with obstructive sleep apnea syndrome: A meta-analysis of randomized controlled trials. Chin Med J (Engl)128, 2365–2373.
17.
KylstraWA, AaronsonJA, HofmanWF, SchmandBA (2013) Neuropsychological functioning after CPAP treatment in obstructive sleep apnea: A meta-analysis. Sleep Med Rev17, 341–347.
18.
JadadAR, MooreRA, CarrollD, JenkinsonC, ReynoldsDJ, GavaghanDJ, McQuayHJ (1996) Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Control Clin Trials17, 1–12.
19.
BarnesM, McEvoyRD, BanksS, TarquinioN, MurrayCG, VowlesN, PierceRJ (2004) Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med170, 656–664.
20.
DalmasesM, Sole-PadullesC, TorresM, EmbidC, NunezMD, Martinez-GarciaMA, FarreR, BargalloN, Bartres-FazD, MontserratJM (2015) Effect of CPAP on cognition, brain function, and structure among elderly patients with OSA: A randomized pilot study. Chest148, 1214–1223.
21.
EnglemanHM, MartinSE, KingshottRN, MackayTW, DearyIJ, DouglasNJ (1998) Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax53, 341–345.
22.
EnglemanHM, KingshottRN, WraithPK, MackayTW, DearyIJ, DouglasNJ (1999) Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am J Respir Crit Care Med159, 461–467.
23.
GastH, SchwalenS, RingendahlH, JörgJ, HirshkowitzM (2006) Sleep-related breathing disorders and continuous positive airway pressure–related changes in cognition. Sleep Med Clin1, 499–511.
Joyeux-FaureM, NaegeleB, PepinJL, TamisierR, LevyP, LaunoisSH (2016) Continuous positive airway pressure treatment impact on memory processes in obstructive sleep apnea patients: A randomized sham-controlled trial. Sleep Med24, 44–50.
26.
Martinez-GarciaMA, ChinerE, HernandezL, CortesJP, CatalanP, PonceS, DiazJR, PastorE, VigilL, CarmonaC, MontserratJM, AizpuruF, LloberesP, MayosM, SelmaMJ, CifuentesJF, MunozA, Spanish Sleep Network (2015) Obstructive sleep apnoea in the elderly: Role of continuous positive airway pressure treatment. Eur Respir J46, 142–151.
27.
McMillanA, BrattonDJ, FariaR, Laskawiec-SzkonterM, GriffinS, DaviesRJ, NunnAJ, StradlingJR, RihaRL, MorrellMJ (2014) Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): A 12-month, multicentre, randomised trial. Lancet Respir Med2, 804–812.
28.
MonasterioC, VidalS, DuranJ, FerrerM, CarmonaC, BarbeF, MayosM, Gonzalez-MangadoN, JuncadellaM, NavarroA, BarreiraR, CapoteF, MayoralasLR, Peces-BarbaG, AlonsoJ, MontserratJM (2001) Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med164, 939–943.
29.
PoggelDA, StrasburgerH (2004) Visual perception in space and time–mapping the visual field of temporal resolution. Acta Neurobiol Exp (Wars)64, 427–437.
30.
UsuiN, HajiT, MaruyamaM, KatsuyamaN, UchidaS, HozawaA, OmoriK, TsujiI, KawashimaR, TairaM (2009) Cortical areas related to performance of WAIS Digit Symbol Test: A functional imaging study. Neurosci Lett463, 1–5.
31.
LauEY, EskesGA, MorrisonDL, RajdaM, SpurrKF (2010) Executive function in patients with obstructive sleep apnea treated with continuous positive airway pressure. J Int Neuropsychol Soc16, 1077–1088.
KimH, JooE, SuhS, KimJH, KimST, HongSB (2016) Effects of long-term treatment on brain volume in patients with obstructive sleep apnea syndrome. Hum Brain Mapp37, 395–409.
34.
GagnadouxF, Le VaillantM, ParisA, PigeanneT, Leclair-VisonneauL, Bizieux-ThaminyA, AlizonC, HumeauMP, NguyenXL, RouaultB, TrzepizurW, MeslierN, Institut de Recherche en Sante Respiratoire des Pays de la Loire Sleep Cohort Group (2016) Relationship between OSA clinical phenotypes and CPAP treatment outcomes. Chest149, 288–290.
35.
CastronovoV, ScifoP, CastellanoA, AloiaMS, IadanzaA, MarelliS, CappaSF, StrambiLF, FaliniA (2014) White matter integrity in obstructive sleep apnea before and after treatment. Sleep37, 1465–1475.
36.
DeeringS, LiuL, ZamoraT, HamiltonJ, StepnowskyC (2017) CPAP adherence is associated with attentional improvements in a group of primarily male patients with moderate to severe OSA. J Clin Sleep Med13, 1423–1428.
37.
BarattaF, PastoriD, BucciT, FabianiM, FabianiV, BrunoriM, LoffredoL, LilloR, PannitteriG, AngelicoF, Del BenM (2018) Long-term prediction of adherence to continuous positive air pressure therapy for the treatment of moderate/severe obstructive sleep apnea syndrome. Sleep Med43, 66–70.
38.
BerkaniK, DimetJ (2015) [Acceptability and compliance to long-term continuous positive pressure treatment]. Rev Mal Respir32, 249–255.
39.
O’DonoghueFJ, WellardRM, RochfordPD, DawsonA, BarnesM, RuehlandWR, JacksonML, HowardME, PierceRJ, JacksonGD (2012) Magnetic resonance spectroscopy and neurocognitive dysfunction in obstructive sleep apnea before and after CPAP treatment. Sleep35, 41–48.
40.
LiguoriC, ChiaravallotiA, IzziF, NuccetelliM, BernardiniS, SchillaciO, MercuriNB, PlacidiF (2017) Sleep apnoeas may represent a reversible risk factor for amyloid-beta pathology. Brain140, e75.
41.
WeaverTE, MaislinG, DingesDF, BloxhamT, GeorgeCF, GreenbergH, KaderG, MahowaldM, YoungerJ, PackAI (2007) Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep30, 711–719.
42.
GulatiA, AliM, DaviesM, QuinnellT, SmithI (2017) A prospective observational study to evaluate the effect of social and personality factors on continuous positive airway pressure (CPAP) compliance in obstructive sleep apnoea syndrome. BMC Pulm Med17, 56.
43.
BoydSB, UpenderR, WaltersAS, GoodpasterRL, StanleyJJ, WangL, ChandrasekharR (2016) Effective Apnea-Hypopnea Index (“Effective AHI”): A new measure of effectiveness for positive airway pressure therapy. Sleep39, 1961–1972.
44.
EnglemanHM, WildMR (2003) Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). Sleep Med Rev7, 81–99.
45.
GarbarinoS, ScodittiE, LanteriP, ConteL, MagnavitaN, ToraldoDM (2018) Obstructive sleep apnea with or without excessive daytime sleepiness: Clinical and experimental data-driven phenotyping. Front Neurol9, 505.
46.
ZinchukAV, GentryMJ, ConcatoJ, YaggiHK (2017) Phenotypes in obstructive sleep apnea: A definition, examples and evolution of approaches. Sleep Med Rev35, 113–123.
